IDG visit to SJHC cancer institute

On March 20, 2025, members of the IDG had the privilege of visiting the Providence Saint John’s Cancer Institute in Santa Monica.
​
​Guided by Dr. Matias Bustos, Ph.D., Assistant Professor, Translational Molecular Medicine, attendees explored the Institute’s cutting-edge research laboratories and advanced equipment, gaining insight into the innovative work being conducted to combat cancer.

The Saint John’s Cancer Institute is renowned for its commitment to translational science and advanced therapeutics, focusing on a wide range of cancers including breast, colorectal, urologic, thoracic, gynecologic, and neurologic malignancies. The visit highlighted the Institute’s state-of-the-art facilities and the collaborative efforts of physicians and researchers striving to improve patient outcomes through groundbreaking research and clinical trials.

Translational molecular medicine is a field of biomedical research that focuses on bridging the gap between laboratory discoveries at the molecular level and their application in clinical practice.